Want to join the conversation?
In 3Q15, excluding the impact of foreign currency, $BXLT's hematology & immunology businesses generated double-digit sales growth. Hematology revenues increased 10% to $935MM as it continues to focus on enhancing access and elevating standards of care worldwide; and Immunology sales advanced 12% to $626MM on a pro forma basis.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?
After so much controversy and family issues in $VIAB over the recent months, Paramount brings in some good news. News is that they signed a $1 billion deal with Shanghai Film Group and Huahua Media. The material impact to Viacom however is still uncertain.